PIEZO1 Gene: Mechanosensitive Ion Channel in Human Health and Disease
A comprehensive biomedical overview of PIEZO1, its structure, function, expression, associated diseases, and clinical significance.
Gene Information Card
| Symbol | PIEZO1 |
|---|---|
| Full Name | Piezo-type mechanosensitive ion channel component 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 16q24.3 (GRCh38) |
| NCBI Gene ID | 9780 ncbi.nlm.nih.gov/gene/9780 |
| Ensembl ID | ENSG00000103335 |
| UniProt ID | Q92508 |
| OMIM ID | 611184 |
| HGNC ID | 28993 |
| Aliases | Mib, FLJ12199, KIAA0233, LMPH3, DHS |
Description
PIEZO1 encodes a large, evolutionarily conserved mechanosensitive ion channel that directly responds to mechanical forces such as membrane stretch and shear stress. It forms a homotrimeric complex with a unique propeller-like structure, featuring a central pore that conducts cations (primarily Ca2+, Na+, and K+). PIEZO1 is critical for various physiological processes including vascular development, red blood cell volume regulation, and cellular mechanotransduction. Mutations in PIEZO1 are associated with hereditary xerocytosis (a red blood cell disorder) and lymphatic dysplasia. The gene is widely expressed across tissues, with particularly high levels in the lung, bladder, and skin. PIEZO1 has also been implicated in cancer biology, where its expression can influence tumor progression and metastasis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hereditary xerocytosis (DHS) | Gain-of-function mutations lead to increased cation permeability and altered red blood cell hydration, causing hemolytic anemia and dehydration of erythrocytes. | ClinVar, OMIM (OMIM: 194380) |
| Lymphatic dysplasia (LMPH3) | Loss-of-function mutations impair lymphatic valve formation and function, leading to primary lymphedema. | OMIM (OMIM: 616561), UniProt |
| Generalized lymphatic dysplasia | Biallelic loss-of-function mutations cause severe lymphatic malformations and fetal hydrops. | OMIM (OMIM: 616561), PubMed (via NCBI) |
| Cancer (various) | Altered PIEZO1 expression or activity can modulate tumor cell invasion, angiogenesis, and mechanosensing in the tumor microenvironment. | COSMIC (cancer.sanger.ac.uk), PubMed (via NCBI) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lung | 34.2 | High |
| Bladder | 28.5 | High |
| Skin | 22.1 | High |
| Kidney | 15.3 | Medium |
| Colon | 12.8 | Medium |
| Spleen | 10.4 | Medium |
| Liver | 6.2 | Low |
| Brain | 4.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| A549 (Lung carcinoma) | 18.5 | High expression; used in mechanotransduction studies |
| HEK 293 (Embryonic kidney) | 12.3 | Commonly used for heterologous expression of PIEZO1 |
| HUVEC (Endothelial) | 20.1 | High expression; relevant to vascular biology |
| K562 (Leukemia) | 8.7 | Moderate expression; erythroid lineage |
| MCF7 (Breast cancer) | 5.2 | Low expression; may be induced under mechanical stress |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| R2456H | Missense | Rare (found in hereditary xerocytosis) | Gain-of-function; increased channel activity |
| R2482H | Missense | Rare (found in hereditary xerocytosis) | Gain-of-function; altered ion selectivity |
| E756del | In-frame deletion | Rare (found in hereditary xerocytosis) | Gain-of-function; increased mechanosensitivity |
| L1342P | Missense | Rare (found in lymphatic dysplasia) | Loss-of-function; reduced channel expression or activity |
| V2015M | Missense | Rare (found in lymphatic dysplasia) | Loss-of-function; impaired channel function |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations typically reduce or abolish PIEZO1 channel activity, leading to impaired mechanotransduction. These are associated with lymphatic dysplasia and lymphedema, as defective valve formation and lymphatic vessel development occur.
Gain of Function (GOF)
Gain-of-function mutations increase channel activity, often by enhancing mechanosensitivity or altering ion conductance. These are linked to hereditary xerocytosis, where increased cation permeability leads to red blood cell dehydration and hemolysis.
Dominant Negative (DN)
Dominant-negative effects have been suggested for some PIEZO1 mutations, where mutant subunits co-assemble with wild-type subunits and impair overall channel function. This mechanism is less clearly defined but may contribute to certain lymphatic phenotypes.
View complete mutation data:
Gene Ontology (GO)
| • Mechanosensitive ion channel activity (GO:0008381) | • Ion channel activity (GO:0005216) |
| • Calcium ion binding (GO:0005509) | • Integral component of plasma membrane (GO:0005887) |
| • Cellular response to mechanical stimulus (GO:0071260) | • Cation transport (GO:0006812) |
| • Regulation of cell volume (GO:0006884) | • Vascular development (GO:0001944) |
Pathways
• Mechanotransduction pathway (via PIEZO1 activation)
• Calcium signaling pathway (downstream of PIEZO1-mediated Ca2+ influx)
• Regulation of actin cytoskeleton (via Rho GTPases
• influenced by PIEZO1)
• Red blood cell homeostasis (volume regulation)
• Lymphatic vessel development (valve formation)
Protein Summary
PIEZO1 is a large transmembrane protein (~2500 amino acids) that forms a trimeric channel with a unique three-bladed propeller architecture. Each monomer consists of 38 transmembrane helices, with a central pore domain that is structurally distinct from other ion channels. The protein undergoes conformational changes in response to membrane tension, opening a non-selective cation pore. PIEZO1 is post-translationally modified (e.g., glycosylation) and interacts with various intracellular partners, including the cytoskeleton and signaling molecules. Its activity is modulated by lipids such as cholesterol and phosphoinositides. The protein is essential for mechanosensation in multiple tissues, and its dysfunction underlies several human diseases.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PIEZO1 Knockout HEK293T Cell Line | EDJ-KQ272 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout HEK293 Cell Line | EDJ-KQ14758 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout A-549 Cell Line | EDJ-KQ45139 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout HCT 116 Cell Line | EDJ-KQ45140 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout HeLa Cell Line | EDJ-KQ45141 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout BEAS-2B Cell Line | EDJ-KZ393 | Human | 9780 | Details Get a Quote |
| PIEZO1 Knockout HT-29 Cell Line | EDJ-KZ395 | Human | 9780 | Details Get a Quote |
Displaying Records 1 To 7 Of 7 Records